The double upgrade adds short-term momentum, but heavy insider selling and elevated short interest warrant caution. Aggressive traders may use the $3.56 level as a support entry, but wait for confirmation from price action or additional upgrades from higher-accuracy firms.
Price Chart
Executive Summary
China Renaissance issued a double upgrade on May 6, 2026, lifting its rating from Hold to Buy with a $5 price target. The stock currently trades at $3.56, offering 40% upside to the new target. The consensus is overwhelmingly bullish: 28 of 30 analysts rate it Buy or Strong Buy, with a mean target of $6.29 implying +77% upside. China Renaissance's track record shows 56% accuracy on 16 calls with an average return of +20.6%. However, this upgrade is not a contrarian call — it aligns with the bullish consensus. Bearish cross-signals include heavy insider selling totaling over $2M in April and a short interest ratio of 55.7%. EPS estimates for the current fiscal year were revised down twice in the past 30 days. Overall, the upgrade adds near-term catalyst but is tempered by conflicting data, warranting a cautious bullish stance.
Impact Score
Consensus & Targets
30 analysts cover the stock: 9 Strong Buy, 19 Buy, 2 Hold, 0 Sell/Strong Sell. The consensus is 93% bullish (Buy or higher), indicating broad Street optimism.
Current price $3.56. Consensus mean PT $6.29, median $6.28, high $8.00, low $4.50. The $5.00 target from China Renaissance sits 20% below the mean and below the low of $4.50, making it the most conservative in the group. Implied upside to mean is +77%.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-06 | China Renaissance | upgrade | Buy | $5.00 |
| 2026-05-05 | JP Morgan | maintain | Overweight | $5.80 |
| 2026-05-05 | Mizuho | maintain | Outperform | $6.00 |
| 2026-04-20 | JP Morgan | maintain | Overweight | — |
| 2026-01-16 | HSBC | upgrade | Buy | $6.20 |
| 2025-11-11 | Barclays | maintain | Overweight | $7.00 |
| 2025-11-04 | Benchmark | maintain | Buy | $7.00 |
| 2025-09-17 | HSBC | downgrade | Hold | $6.20 |
| 2025-04-16 | JP Morgan | maintain | Overweight | $5.30 |
| 2025-02-21 | JP Morgan | upgrade | Overweight | $5.60 |
Analyst activity in the past 30 days: 1 upgrade (China Renaissance), 0 downgrades. EPS revisions: The current fiscal year saw 2 downward revisions in 30 days, with the average EPS estimate falling from $0.0915 to $0.0888. Next fiscal year estimates are flat (1 up, 1 down). Overall, estimates are trending slightly lower.
Firm Track Record — China Renaissance
China Renaissance accuracy: 56% on 16 calls | avg return: 20.6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 5 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Mizuho | 100% | 2/2 | 5.1% | top tier |
| HSBC | 67% | 2/3 | -4.1% | top tier |
| JP Morgan | 67% | 2/3 | 9.1% | top tier |
| Benchmark | 57% | 4/7 | 10.7% | above average |
| Barclays | 50% | 2/4 | -9.2% | below average |
China Renaissance has a 56% accuracy rate on 16 calls with an average return of +20.6%. Among peers, Mizuho (100%, 2 calls), HSBC (67%, 3), JPMorgan (67%, 3) and Benchmark (57%, 7) perform better, while Barclays (50%, 4) is similar. China Renaissance's higher sample size adds credibility, but its accuracy is mid-tier.
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0y | $0.09 | $0.07 — $0.11 | $4.1B | ↑0 ↓0 |
| +1q | $0.02 | $0.02 — $0.02 | $989.1M | ↑0 ↓0 |
| +1y | $0.15 | $0.14 — $0.16 | $4.9B | ↑0 ↓0 |
| 0q | $0.01 | $0.01 — $0.01 | $920.2M | ↑0 ↓0 |
Cross-Platform Signals
Insider trades show consistent selling: $2M in April by officers. No congressional trades recorded. No institutional position changes reported. Short interest stands at 12.2M shares, a 55.7% short ratio — extremely high. This divergence (bullish analyst upgrade vs. bearish insider/short signals) suggests the upgrade alone may not be sufficient to reverse sentiment.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | Insider Cluster | $2.89 | awaiting T+5 | — | $2.71 (−6.23%) |
Sep 21, 2026 4w ago | Insider Cluster | $3.17 $3.12 | ▼ −1.58% | ▼ −0.39% | $2.71 (−14.51%) |
Sep 17, 2026 5w ago | Insider Cluster | $2.80 $3.13 | ▲ +11.99% | ▲ +10.72% | $2.71 (−3.04%) |
Sep 15, 2026 5w ago | 6-K | $2.91 $3.17 | ▲ +8.93% | ▲ +6.82% | $2.71 (−6.87%) |
Sep 8, 2026 6w ago | Insider Cluster | $3.04 $2.87 | ▲ +5.59% | ▲ +4.50% | $2.71 (+10.86%) |
Aug 19, 2026 9w ago | Insider Cluster | $3.51 $3.59 | ▲ +2.28% | ▲ +1.16% | $2.71 (−22.79%) |
Aug 18, 2026 9w ago | Insider Cluster | $3.54 $3.64 | ▲ +2.82% | ▲ +3.21% | $2.71 (−23.45%) |
Aug 12, 2026 10w ago | Insider Cluster | $3.70 $3.51 | ▼ −5.14% | ▼ −3.17% | $2.71 (−26.76%) |
Jul 17, 2026 14w ago | Insider Cluster | $3.62 $3.31 | ▼ −8.56% | ▼ −8.14% | $2.71 (−25.14%) |
Jul 15, 2026 14w ago | Insider Cluster | $3.73 $3.30 | ▼ −11.53% | ▼ −9.86% | $2.71 (−27.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers